Atlas Arteria Stock Forecast for 2023 - 2025 - 2030
Updated on 04/20/2024
Atlas Arteria Stock Forecast and Price Target
If Atlas Arteria's stock price reached the average yearlong target of $5.70 given by well-known analysts in recent months, there would be a potential upside of approximately 6.34% from its last closing price in April, 2024. This potential increase is based on a high estimate of $6.37 and a low estimate of $5.29. If you're not interested in ALX stock, you may be interested in its competitors.
6.34% Upside
Atlas Arteria Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Atlas Arteria's Price has decreased by 100.00%, going from $3.31 to $0.00. For next year, analysts predict Fair Value of $15.32, which would mean an increase of 100.00%. Over the next nine years, experts predict that Atlas Arteria's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TTE Stock Forecast | TotalEnergies | Outperform |
9
|
67.28€ | Buy/Sell | 70.73€ | 12.90% |
| ALV Stock Forecast | Allianz | Outperform |
10
|
263.20€ | Buy/Sell | 267.63€ | 5.05% |
| ADP Stock Forecast | Automatic Data Processing Inc | Hold |
17
|
$243.31 | Buy/Sell | $249.51 | 6.37% |
| CS Stock Forecast | AXA | Outperform |
10
|
33.90€ | Buy/Sell | 32.17€ | 9.14% |
| DG Stock Forecast | VINCI | Outperform |
10
|
113.35€ | Buy/Sell | 133.72€ | 17.78% |
Atlas Arteria Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Atlas Arteria's Revenue has grown by 25.64%, rising from $106.65M to $134.00M. For next year, analysts predict Revenue of $328.40M, which would mean an increase of 145.07%. Over the next nine years, experts predict that Atlas Arteria's Revenue will grow at a rate of 155.31%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MQG Stock Forecast | Macquarie Group | Outperform |
9
|
$183.33 | Buy/Sell | $182.49 | 3.47% |
| ENGI Stock Forecast | Engie | Outperform |
6
|
15.93€ | Buy/Sell | 18.17€ | 15.19% |
| PGHN Stock Forecast | Partners Group Holding | Outperform |
10
|
CHF1.19k | Buy/Sell | CHF1.07k | 5.97% |
.jpg)
Atlas Arteria Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Atlas Arteria's Dividend per Share has grown, rising from $0.11 to $0.40 – a growth of 263.64%. In the next year, analysts believe that Dividend per Share will reach $0.41 – an increase of 2.50%. For the next eleven years, the forecast is for Dividend per Share to grow by 40.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| III Stock Forecast | 3i Group | Outperform |
17
|
£28.35 | Buy/Sell | £24.06 | 4.76% |
| FER Stock Forecast | Ferrovial | Outperform |
15
|
33.22€ | Buy/Sell | 31.50€ | 13.64% |
| TCL Stock Forecast | Transurban Group | Hold |
13
|
$12.75 | Buy/Sell | $13.56 | 5.10% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| EN Stock Forecast | Bouygues | Hold |
18
|
36.12€ | Buy/Sell | 34.68€ | 3.13% |
| FGR Stock Forecast | Eiffage | Outperform |
18
|
98.82€ | Buy/Sell | 119.30€ | 26.49% |
| HOT Stock Forecast | HOCHTIEF | Outperform |
17
|
104.90€ | Buy/Sell | 86.23€ | 2.00% |
Atlas Arteria EBITDA Forecast for 2023 - 2025 - 2030
Atlas Arteria's EBITDA has seen impressive growth In the last three years, rising from $38.84M to $64.10M – a growth of 65.04%. In the next year, analysts believe that EBITDA will reach $164.62M – an increase of 156.82%. For the next seven years, the forecast is for EBITDA to grow by 249.95%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SDR Stock Forecast | Schroders | Hold |
18
|
£3.67 | Buy/Sell | £4.41 | 18.53% |
| GICRE Stock Forecast | General Insurance Corporation ... | Hold |
12
|
Rp324.60 | Buy/Sell | Rp239.25 | -3.73% |
| SCR Stock Forecast | SCOR | Outperform |
18
|
29.18€ | Buy/Sell | 32.29€ | 19.26% |
Atlas Arteria EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Atlas Arteria has seen a decline in its EBIT, from $-28.60M to $-5.10M – a 82.17% decrease. According to the 1 analysts polled, in the next year, Atlas Arteria's EBIT will fall by 2738.43%, reaching $134.56M. By 2030, professionals believe that Atlas Arteria's EBIT will have decreased by 2799.27%, falling to $137.66M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| STR Stock Forecast | Strabag | Buy |
18
|
38.10€ | Buy/Sell | 55.00€ | 33.86% |
| NEOEN Stock Forecast | Neoen | Outperform |
12
|
29.94€ | Buy/Sell | 31.39€ | 0.20% |
| HICL Stock Forecast | HICL Infrastructure PLC | Outperform |
10
|
£1.23 | Buy/Sell | £1.57 | 24.39% |
Atlas Arteria EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Atlas Arteria's EPS has decreased by 100.00%, going from $0.08 to $0.00. For next year, analysts predict EPS of $0.37, which would mean an increase of 100.00%. Over the next nine years, experts predict that Atlas Arteria's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PEUG Stock Forecast | Peugeot Invest Société anony... | Outperform |
17
|
110.00€ | Buy/Sell | 132.50€ | 31.82% |
| VLTSA Stock Forecast | Voltalia | Outperform |
12
|
7.54€ | Buy/Sell | 14.40€ | 59.15% |
| BAMNB Stock Forecast | Koninklijke BAM Groep nv | Buy |
10
|
3.79€ | Buy/Sell | 2.90€ | 26.12% |
.jpg)